Metraipolis › archive › dc_ea41b5ce3e64

Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study — Europe PMC PMID:41799021

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41799021
DOI: 10.3389/fped.2025.1575014
License (as archived): solo-consultazione
Archived: 2026-11-05T14:03:20.112Z
SHA-256 of the archived text: ba96e51a5b9043822c197e4fa913f6ea6e503a5a5e5fe54d4b26178614f5611c
Stable URL of this page: https://metraipolis.com/documento/dc_ea41b5ce3e64

How to cite

Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study — Europe PMC PMID:41799021 — Europe PMC (en), https://europepmc.org/article/MED/41799021 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea41b5ce3e64 (Metraipolis archive dc_ea41b5ce3e64, sha256 ba96e51a5b9043822c197e4fa913f6ea6e503a5a5e5fe54d4b26178614f5611c)

BibTeX

@misc{dcea41b5ce3e64,
  title = {Ketogenic drug tricaprilin (CER-0001) for the treatment of refractory infantile epileptic spasms: a phase 1/2a study — Europe PMC PMID:41799021},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41799021},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea41b5ce3e64; sha256 ba96e51a5b9043822c197e4fa913f6ea6e503a5a5e5fe54d4b26178614f5611c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41799021. Agents can read the archived copy with the MCP tool read_document.